We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+17.46%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$1.94B
AUM Growth
+$209M
Cap. Flow
+$157M
Cap. Flow %
8.08%
Top 10 Hldgs %
37.79%
Holding
268
New
72
Increased
34
Reduced
55
Closed
76

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$16.3M
2
SONX
Sonendo, Inc.
SONX
+$7.34M
3
NTRA icon
Natera
NTRA
+$6.8M
4
AZTA icon
Azenta
AZTA
+$6.45M
5
QTRX icon
Quanterix
QTRX
+$5.89M

Top Sells

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$22.4M
2
ILMN icon
Illumina
ILMN
+$11.7M
3
AZN icon
AstraZeneca
AZN
+$9.6M
4
OM icon
Outset Medical
OM
+$8.46M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$7.3M

Sector Composition

Rank Sector Weight
1 Healthcare 27.35%
2 Industrials 0.25%
3 Materials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NKTR icon
226
CALL
Nektar Therapeutics
NKTR
$2.57B
– –
-2,440
Closed -$117K
NTLA icon
227
PUT
Intellia Therapeutics
NTLA
$1.69B
– –
-100,300
Closed -$5.61M
NTRA icon
228
CALL
Natera
NTRA
$45.5B
– –
-100,000
Closed -$4.38M
PACB icon
229
PUT
Pacific Biosciences
PACB
$345M
– –
-1,700,000
Closed -$9.86M
PFE icon
230
Pfizer
PFE
$150B
– –
-50,000
Closed -$2.4M
PRVA icon
231
Privia Health
PRVA
$2.75B
– –
-135,000
Closed -$3.76M
RCEL icon
232
CALL
Avita Medical
RCEL
$251M
– –
-450,000
Closed -$2.37M
RCKT icon
233
Rocket Pharmaceuticals
RCKT
$374M
– –
-50,000
Closed -$921K
RMD icon
234
ResMed
RMD
$32.8B
– –
-15,000
Closed -$3.27M
RNAM
235
DELISTED
Avidity Biosciences
RNAM
– –
-18,506
Closed -$302K
RVMD icon
236
Revolution Medicines
RVMD
$44B
– –
-95,000
Closed -$1.87M
SAM icon
237
PUT
Boston Beer
SAM
$1.89B
– –
-40,000
Closed -$12.9M
SNY icon
238
Sanofi
SNY
$105B
– –
-97,684
Closed -$3.71M
STE icon
239
PUT
Steris
STE
$23.1B
– –
-30,000
Closed -$4.99M
TDOC icon
240
PUT
Teladoc Health
TDOC
$1.22B
– –
-300,000
Closed -$7.61M
TFX icon
241
PUT
Teleflex
TFX
$6.03B
– –
-35,000
Closed -$7.05M
THC icon
242
Tenet Healthcare
THC
$21.5B
– –
-100,000
Closed -$5.16M
TNDM icon
243
CALL
Tandem Diabetes Care
TNDM
$1.63B
– –
-100,000
Closed -$4.79M
TNDM icon
244
Tandem Diabetes Care
TNDM
$1.63B
– –
-75,000
Closed -$3.59M
TXG icon
245
PUT
10x Genomics
TXG
$7.52B
– –
-100,000
Closed -$2.85M
VERU icon
246
CALL
Veru
VERU
$46.7M
– –
-20,000
Closed -$2.3M
VRNA
247
DELISTED
Verona Pharma
VRNA
– –
-100,000
Closed -$1.02M
WBA
248
PUT
DELISTED
Walgreens Boots Alliance
WBA
– –
-250,000
Closed -$7.85M
ZBH icon
249
CALL
Zimmer Biomet
ZBH
$18.7B
– –
-50,000
Closed -$5.23M
AGTI
250
DELISTED
Agiliti Inc
AGTI
– –
-49,200
Closed -$704K
7 8 9
10
11

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q4 2022 Portfolio in Review

As of Q4 2022, Pura Vida Investments held 268 positions worth $1.94B, up 12% from $1.73B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Pura Vida Investments deployed $157M of net new capital in Q4 2022, opening 72 new positions and adding to 34 existing holdings. Its largest new stake was Natera: 165,000 shares worth $6.63M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 35% a quarter earlier, followed by Industrials and Materials.

On the sell side, the largest reduction was United Therapeutics, an estimated $22.4M trimmed.

  • Pura Vida Investments's largest Q4 2022 buy was Natera: 165,000 shares worth $6.63M.
  • Pura Vida Investments added most to Biogen in Q4 2022, an estimated $16.3M increase.
  • Pura Vida Investments's biggest Q4 2022 reduction was United Therapeutics, cutting an estimated $22.4M.
  • Pura Vida Investments fully exited Illumina in Q4 2022, selling an estimated $11.7M.
  • Pura Vida Investments's ten largest holdings make up 38% of its $1.94B portfolio in Q4 2022.
  • Pura Vida Investments opened 72 new positions and closed 76 in Q4 2022.
  • Pura Vida Investments's portfolio value rose 12% quarter-over-quarter to $1.94B.

Based on Pura Vida Investments's 13F filing for Q4 2022, filed 14 Feb 2023.